Concepedia

Joel Isohookana

JI

Statistics

Publications

7

Citations

184

H-Index

7

Active since

2015

Affiliations

Oulu University Hospital(Current)

University of Oulu

Karolinska Institutet

Karolinska University Hospital

University of Eastern Finland

Joel Isohookana is an author at Oulu University Hospital specializing in medicine, cancer research, and immunology.

ORCID

Top concepts

Publications per year

2015–2018

7

Publications

7

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma

Joni Leppänen, Ville Lindholm, Joel Isohookana et al. · Pancreas · 2018 · 60 citations · Full text

High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients

Joni Leppänen, Olli Helminen, Heikki Huhta et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2017 · 31 citations

, , +9

Toll‐like receptors 2, 4 and 9 and hypoxia markers <scp>HIF</scp>‐1alpha and <scp>CAIX</scp> in pancreatic intraepithelial neoplasia

Joni Leppänen, Olli Helminen, Heikki Huhta et al. · Apmis · 2018 · 29 citations

, , +18

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas

Joel Isohookana, Kirsi‐Maria Haapasaari, Ylermi Soini et al. · Diagnostic Pathology · 2015 · 23 citations · Full text

Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma

Joel Isohookana, Kirsi‐Maria Haapasaari, Ylermi Soini et al. · Pathology - Research and Practice · 2018 · 17 citations · Full text

, , +9

1–5 of 7